Mani Foroohar
Stock Analyst at Leerink Partners
(0.47)
# 4,042
Out of 4,399 analysts
944
Total ratings
42.8%
Success rate
-2.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mani Foroohar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABSI Absci | Initiated Coverage: Buy | $12 | $6.38 | +88.09% | 1 | Jun 4, 2026 | |
| RGNX REGENXBIO | Maintained: Buy | $17 | $6.13 | +177.32% | 64 | May 15, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $100 → $154 | $94.00 | +63.83% | 54 | May 15, 2026 | |
| ENGN enGene Therapeutics | Downgraded: Hold | $14 → $2 | $1.60 | +25.00% | 13 | May 8, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Buy | $27 → $35 | $12.20 | +186.89% | 52 | Apr 27, 2026 | |
| CAMP Camp4 Therapeutics | Maintained: Buy | $8 → $9 | $4.34 | +107.37% | 7 | Apr 2, 2026 | |
| RCKT Rocket Pharmaceuticals | Rated: Hold | $7 → $11 | $2.60 | +323.08% | 55 | Mar 27, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Hold | n/a | $70.73 | - | 56 | Mar 26, 2026 | |
| MRNA Moderna | Maintained: Sell | $12 | $45.99 | -73.91% | 89 | Feb 11, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Hold | $370 → $351 | $291.22 | +20.53% | 67 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $100 | $73.38 | +36.28% | 67 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 → $86 | $67.41 | +27.59% | 76 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $2 | $0.6983 | +186.41% | 16 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $18 | $4.13 | +335.84% | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $74 | $49.44 | +49.68% | 27 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.72 | - | 41 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.04 | - | 34 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $48 | $44.09 | +8.87% | 2 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $10.39 | +92.49% | 9 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $29.49 | - | 20 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $27 | $14.15 | +90.81% | 12 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.79 | +67.60% | 32 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $28.01 | +149.91% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $2.48 | n/a | 20 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $4.18 | n/a | 31 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.2945 | n/a | 3 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 | $6.58 | n/a | 15 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $10.00 | n/a | 1 | Jun 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $5.66 | n/a | 24 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $6 | $5.36 | n/a | 17 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $28.18 | n/a | 7 | Oct 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $216 → $197 | $15.11 | n/a | 3 | Nov 6, 2020 |
Absci
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $6.38
Upside: +88.09%
REGENXBIO
May 15, 2026
Maintained: Buy
Price Target: $17
Current: $6.13
Upside: +177.32%
Mirum Pharmaceuticals
May 15, 2026
Maintained: Buy
Price Target: $100 → $154
Current: $94.00
Upside: +63.83%
enGene Therapeutics
May 8, 2026
Downgraded: Hold
Price Target: $14 → $2
Current: $1.60
Upside: +25.00%
Intellia Therapeutics
Apr 27, 2026
Reiterated: Buy
Price Target: $27 → $35
Current: $12.20
Upside: +186.89%
Camp4 Therapeutics
Apr 2, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $4.34
Upside: +107.37%
Rocket Pharmaceuticals
Mar 27, 2026
Rated: Hold
Price Target: $7 → $11
Current: $2.60
Upside: +323.08%
Arrowhead Pharmaceuticals
Mar 26, 2026
Maintained: Hold
Price Target: n/a
Current: $70.73
Upside: -
Moderna
Feb 11, 2026
Maintained: Sell
Price Target: $12
Current: $45.99
Upside: -73.91%
Alnylam Pharmaceuticals
Dec 15, 2025
Maintained: Hold
Price Target: $370 → $351
Current: $291.22
Upside: +20.53%
Dec 15, 2025
Maintained: Buy
Price Target: $68 → $100
Current: $73.38
Upside: +36.28%
Dec 15, 2025
Maintained: Buy
Price Target: $370 → $86
Current: $67.41
Upside: +27.59%
Dec 15, 2025
Maintained: Buy
Price Target: $3 → $2
Current: $0.6983
Upside: +186.41%
Oct 21, 2025
Maintained: Buy
Price Target: $20 → $18
Current: $4.13
Upside: +335.84%
Oct 15, 2025
Maintained: Buy
Price Target: $56 → $74
Current: $49.44
Upside: +49.68%
Oct 15, 2025
Maintained: Buy
Price Target: n/a
Current: $8.72
Upside: -
Oct 15, 2025
Maintained: Hold
Price Target: n/a
Current: $3.04
Upside: -
Sep 25, 2025
Maintained: Buy
Price Target: $51 → $48
Current: $44.09
Upside: +8.87%
Sep 23, 2025
Reiterated: Buy
Price Target: $20
Current: $10.39
Upside: +92.49%
Sep 3, 2025
Maintained: Buy
Price Target: n/a
Current: $29.49
Upside: -
Aug 18, 2025
Maintained: Buy
Price Target: $32 → $27
Current: $14.15
Upside: +90.81%
Aug 13, 2025
Reiterated: Buy
Price Target: $3
Current: $1.79
Upside: +67.60%
Aug 12, 2025
Reiterated: Buy
Price Target: $70
Current: $28.01
Upside: +149.91%
Mar 6, 2025
Maintained: Hold
Price Target: $1
Current: $2.48
Upside: n/a
Aug 9, 2024
Maintained: Hold
Price Target: $1
Current: $4.18
Upside: n/a
Jul 15, 2024
Maintained: Buy
Price Target: n/a
Current: $0.2945
Upside: n/a
Nov 13, 2023
Maintained: Hold
Price Target: $21
Current: $6.58
Upside: n/a
Jun 8, 2023
Maintained: Sell
Price Target: n/a
Current: $10.00
Upside: n/a
May 23, 2023
Reiterated: Hold
Price Target: $6 → $5
Current: $5.66
Upside: n/a
Nov 14, 2022
Reiterated: Hold
Price Target: $5 → $6
Current: $5.36
Upside: n/a
Oct 19, 2021
Maintained: Hold
Price Target: n/a
Current: $28.18
Upside: n/a
Nov 6, 2020
Maintained: Buy
Price Target: $216 → $197
Current: $15.11
Upside: n/a